AbbVie bullish on Humira and near-term pipeline
AbbVie, blood cancer, cancer, Eli Lilly, Humira, inflammatory diseases, psoriasis, Rheumatoid arthritis, Richard Gonzalez
0 Comment
Sales of Humira could peak above $18 billion – CEO